Side-by-side comparison of AI visibility scores, market position, and capabilities
Cambridge MA energy equipment spin-off from GE (NYSE: GEV) at $34.9B revenue 2024; 7,000+ gas turbines and 55,000 wind turbines generating 25-30% of global electricity competing with Siemens Energy and Vestas for energy transition equipment.
GE Vernova is a Cambridge, Massachusetts-based global energy equipment and services company — publicly traded on the New York Stock Exchange (NYSE: GEV) — that emerged as an independent entity in April 2024 following its spin-off from General Electric, employing approximately 75,000 people across 100 countries and focused on accelerating the energy transition through three core business segments: Power (gas turbines, nuclear, and steam solutions), Wind (onshore and offshore wind turbines), and Electrification (grid solutions, power conversion, and electrification software). Generating $34.9 billion in revenue in 2024 with strong growth across all segments, GE Vernova operates more than 7,000 gas turbines and 55,000 wind turbines globally — equipment that generates approximately 25-30% of the world's electricity.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.